daratumumab,lenalidomide,dexamethasone,carfilzomib
janssen
['thanks', 'master trial', 'mmsm']
thanks for stopping by ! such great insights on the final analysis of the master trial examining quadruplet induction therapy, asct, &amp; mrd-modulated consolidation &amp; therapy cessation in #myeloma. #eha2023 #mmsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.